Taprizosin
Taprizosin (UK-338003) is an orally bioavailable, selective α1-adrenoceptor antagonist used in research for benign prostatic hyperplasia. It facilitates vasodilation and is employed in both in vitro binding assays and in vivo models to study urinary tract smooth muscle relaxation.
Product Specifications
CAS Number
210538-44-6
Product Name Alternative
Adrenergic Receptor, AdrenergicReceptor, UK 338003, UK-338,003, UK338003, UK-338003, α1-adrenergic receptor, Taprizosin, Taprizosin Mesylate
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Purity
96.34% (May vary between batches)
Solubility
DMSO:60 mg/mL (118.44 mM)
Smiles
NC=1C=2C (=C (OC) C (OC) =CC2N=C (N1) N3CC=4C (CC3) =C (NS (C) (=O) =O) C=CC4) C5=CC=CC=N5
Molecular Formula
C25H26N6O4S
Molecular Weight
506.58
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
E3373-09G-ML550 100 µL
EphB6, CT (H990) (Ephrin Type-A Receptor 6, Tyrosine-protein Kinase Receptor EPH-6, HEP) (MaxLight 550) discontinued
Sign In for Pricing
View Details 